Dopamine, Noradrenaline and Serotonin Receptor Densities in the Striatum of Hemiparkinsonian Rats following Botulinum Neurotoxin-A Injection.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Neuroscience

• Publication date

  2018-03-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.neuroscience.2018.01.053PMID 29421436
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intrastriatally injected botulinum neurotoxin-A differently effects cholinergic and dopaminergic fibers in C57BL/6 mice.

  2017cited by this paper
• The significance of rotational behavior and sensitivity of striatal dopamine receptors in hemiparkinsonian rats: A comparative study of lactacystin and 6-OHDA.

  2017cited by this paper
• 5HT2A receptor blockade in dorsomedial striatum reduces repetitive behaviors in BTBR mice

  2017cited by this paper
• Maladaptive Synaptic Plasticity in L-DOPA-Induced Dyskinesia

  2016cited by this paper
• Dopaminergic Medication Modulates Learning from Feedback and Error-Related Negativity in Parkinson’s Disease: A Pilot Study

  2016cited by this paper
• Intrastriatal injection of botulinum neurotoxin-A is not cytotoxic in rat brain - A histological and stereological analysis.

  2016cited by this paper
• Synaptic signalling and its interface with neuropathologies: snapshots from the past, present and future

  2016cited by this paper
• Changes in the expression of neurotransmitter receptors in Parkin and DJ-1 knockout mice--A quantitative multireceptor study.

  2015cited by this paper
• Nonpharmacological treatments for patients with Parkinson's disease

  2015cited by this paper
• New insight into the therapeutic role of the serotonergic system in Parkinson's disease.

  2015cited by this paper
• Expression of human mitochondrial transcriptional factor A (hTFAM) improves cognitive function in Alzheimer?s disease model mice

  2014cited by this paper
• Simvastatin reverses the downregulation of M1/4 receptor binding in 6-hydroxydopamine-induced parkinsonian rats: the association with improvements in long-term memory.

  2014cited by this paper
• Differential effects of the NMDA receptor antagonist MK-801 on dopamine receptor D1- and D2-induced abnormal involuntary movements in a preclinical model.

  2014cited by this paper
• he effects of unilateral 6-OHDA lesion in medial forebrain bundle on he motor , cognitive dysfunctions and vulnerability of different triatal interneuron types in rats

  2014cited by this paper
• Behavioral and structural effects of unilateral intrastriatal injections of botulinum neurotoxin a in the rat model of Parkinson's disease

  2013cited by this paper
• Intracerebrally applied botulinum neurotoxin in experimental neuroscience.

  2013cited by this paper
• Basal ganglia circuits changes in Parkinson's disease patients.

  2012cited by this paper
• Effects of intrastriatal botulinum neurotoxin A on the behavior of Wistar rats.

  2012cited by this paper
• Updates in the medical management of Parkinson disease

  2012cited by this paper
• Evaluation of dopamine transporters and D2 receptors in hemiparkinsonian rat brains in vivo using consecutive PET scans of [18F]FPCIT and [18F]fallypride.

  2012cited by this paper
• The emerging role of norepinephrine in cognitive dysfunctions of Parkinson's disease

  2012cited by this paper
• Intrastriatal botulinum toxin abolishes pathologic rotational behaviour and induces axonal varicosities in the 6-OHDA rat model of Parkinson's disease.

  2011cited by this paper
• Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease

  2011cited by this paper
• Dynamic changes of striatal dopamine D2 receptor binding at later stages after unilateral lesions of the medial forebrain bundle in Parkinsonian rat models.

  2011cited by this paper
• A guide to neurotoxic animal models of Parkinson's disease.

  2011cited by this paper
• Changes in the mRNA Levels of α2A and α2C Adrenergic Receptors in Rat Models of Parkinson’s Disease and l-DOPA-Induced Dyskinesia

  2011cited by this paper
• Alterations in 5‐HT2A receptor binding in various brain regions among 6‐hydroxydopamine‐induced Parkinsonian rats

  2010cited by this paper
• Role of adrenoceptors in the regulation of dopamine/DARPP‐32 signaling in neostriatal neurons

  2010cited by this paper
• A reappraisal of the central effects of botulinum neurotoxin type A: by what mechanism?

  2009cited by this paper
• Light and electron microscopic localization of alpha-1 adrenergic receptor immunoreactivity in the rat striatum and ventral midbrain.

  2009cited by this paper
• Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders.

  2008cited by this paper
• 5-HT Receptor Regulation of Neurotransmitter Release

  2007cited by this paper
• Re-emergence of striatal cholinergic interneurons in movement disorders.

  2007cited by this paper
• Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.

  2007cited by this paper
• Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.

  2007cited by this paper
• Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease.

  2006cited by this paper
• Fatty acids differentially affect serotonin receptor and transporter binding in the rat brain.

  2006cited by this paper
• Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society‐European Section (MDS‐ES). Part II: late (complicated) Parkinson's disease

  2006cited by this paper
• Asymmetrical changes of dopamine receptors in the striatum after unilateral dopamine depletion.

  2005cited by this paper
• Evidence‐based medical review update: Pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004

  2005cited by this paper
• Regional and subtype selective changes of neurotransmitter receptor density in a rat transgenic for the Huntington's disease mutation

  2005cited by this paper
• Lithium-induced polydipsia: Dependence on nigrostriatal dopamine pathway and relationship to changes in the renin-angiotensin system

  2004cited by this paper
• Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: release from adrenergic terminals and modulation by alpha2-autoreceptors.

  2004cited by this paper
• Persistent Increase in Olfactory Type G-Protein α Subunit Levels May Underlie D1 Receptor Functional Hypersensitivity in Parkinson Disease

  2004cited by this paper
• Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: release from adrenergic terminals and modulation by α2-autoreceptors

  2004cited by this paper
• Transmitter receptors and functional anatomy of the cerebral cortex

  2004cited by this paper
• Description of Parkinson's Disease as a Clinical Syndrome

  2003cited by this paper
• Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: Intrastriatal microinjection studies in the 6‐OHDA‐lesioned rat

  2002cited by this paper
• Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway.

  2002cited by this paper
• Architectonics of the human cerebral cortex and transmitter receptor fingerprints: reconciling functional neuroanatomy and neurochemistry.

  2002cited by this paper
• 21 – Quantitative Analysis of Cyto- and Receptor Architecture of the Human Brain

  2002cited by this paper
• Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study.

  2001cited by this paper
• Dopamine D(1) receptor expression in human basal ganglia and changes in Parkinson's disease.

  2001cited by this paper
• Dopamine D1 receptor expression in human basal ganglia and changes in Parkinson's disease

  2001cited by this paper
• Functional changes of the basal ganglia circuitry in Parkinson's disease.

  2000cited by this paper
• Cellular localization of serotonin(2A) (5HT(2A)) receptors in the rat brain.

  2000cited by this paper
• Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats

  2000cited by this paper
• Temporal changes of dopaminergic and glutamatergic receptors in 6-hydroxydopamine-treated rat brain.

  2000cited by this paper
• Interactive modulation by dopamine and serotonin neurons of receptor sensitivity of the alternate neurochemical system.

  1999cited by this paper
• The “Psychic” Neuron of the Cerebral Cortex

  1999cited by this paper
• Adrenergic alpha2C-receptors reside in rat striatal GABAergic projection neurons: comparison of radioligand binding and immunohistochemistry.

  1999cited by this paper
• SPECT imaging of pre- and postsynaptic dopaminergic alterations in l-dopa–untreated PD

  1999cited by this paper
• 123I‐β‐CIT and 123I‐IBZM‐SPECT scanning in levodopa‐naive Parkinson's disease

  1998cited by this paper
• Post-synaptic 5-HT1A and 5-HT2A receptors are increased in Parkinson's disease neocortex.

  1998cited by this paper
• Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.

  1998cited by this paper
• The early diagnosis of parkinson's disease

  1998cited by this paper
• Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-, and D4-like receptors.

  1998cited by this paper
• 123I-beta-CIT and 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's disease.

  1998cited by this paper
• Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907

  1997cited by this paper
• In vivo studies on striatal dopamine D1 and D2 site binding in L-dopa-treated Parkinson's disease patients with and without dyskinesias

  1997cited by this paper
• Serotonin, dopamine, and motor effects in Parkinson's disease.

  1997cited by this paper
• Alpha2-adrenergic control of dopamine overflow and metabolism in mouse striatum.

  1997cited by this paper
• The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments.

  1996cited by this paper
• DA Uptake Sites, D1, and D2 Receptors, D2 and Preproenkephalin mRNAs and Fos Immunoreactivity in Rat Striatal Subregions after Partial Dopaminergic Degeneration

  1996cited by this paper
• Distribution of α2C‐adrenergic receptor‐like immunoreactivity in the rat central nervous system

  1996cited by this paper
• The effect of dopamine D1 receptor stimulation on the up‐regulation of histamine H3‐receptors following destruction of the ascending dopaminergic neurones

  1996cited by this paper
• Characteristic upregulation of dopamine D1-receptor in rat striatum after 6-hydroxydopamine treatment.

  1996cited by this paper
• Long-term effects of human-to-rat mesencephalic xenografts on rotational behavior, striatal dopamine receptor binding, and mRNA levels.

  1995cited by this paper
• Pharmacological and nonpharmacological interventions in the treatment of Parkinson's disease.

  1995cited by this paper
• Interhemispheric modulation of dopamine receptor interactions in unilateral 6‐OHDA rodent model

  1995cited by this paper
• Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test

  1995cited by this paper
• Alpha1‐adrenergic Effects on Dopamine Neurons Recorded Intracellularly in the Rat Midbrain Slice

  1995cited by this paper
• Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine.

  1995cited by this paper
• Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy.

  1995cited by this paper
• Time dependent changes in DA uptake sites, D1 and D2 receptor binding and mRNA after 6-OHDA lesions of the medial forebrain bundle in the rat brain.

  1995cited by this paper
• Presynaptic α2A-adrenoceptors inhibit the release of endogenous dopamine in rabbit caudate nucleus slices

  1994cited by this paper
• Hypersensitivity to serotonin and its agonists in serotonin-hyperinnervated neostriatum after neonatal dopamine denervation.

  1994cited by this paper
• Clostridial neurotoxins in the age of molecular medicine.

  1994cited by this paper
• Dopamine D1 receptors in Parkinson's disease and striatonigral degeneration: a positron emission tomography study.

  1993cited by this paper
• Motor response complications and the function of striatal efferent systems

  1993cited by this paper
• Regional distribution and heterogeneity of alpha-adrenoceptors in the rat and human central nervous system.

  1993cited by this paper
• Dopamine receptors status after unilateral nigral 6-OHDA lesion. Autoradiographic and in situ hybridization study in the rat brain.

  1993cited by this paper
• Localization of dopamine D2 receptor protein in rat brain using polyclonal antibody.

  1992cited by this paper
• D2 dopamine receptor localization on striatonigral neurons.

  1992cited by this paper
• Intrastriatal Dopamine‐rich Implants Reverse the Increase of Dopamine D2 Receptor mRNA Levels Caused by Lesion of the Nigrostriatal Pathway: A Quantitative In Situ Hybridization Study

  1992cited by this paper
• A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques.

  1992cited by this paper
• Neurotransmitter receptors and cortical architecture.

  1991cited by this paper
• Regional and laminar distributions of alpha 1-adrenoceptors and their subtypes in human and rat hippocampus.

  1991cited by this paper
• Beta‐adrenergic receptor subtypes in the basal ganglia of patients with Huntington's chorea and Parkinson's disease

  1991cited by this paper
• D1 and D2 dopamine receptor mRNA in rat brain.

  1991cited by this paper

• Focused Modulation of Brain Activity: A Narrative Review

  2025cites this paper
• β-2 agonist and antagonist adrenoceptors induce neuroprotection in a progressive model of parkinsonism.

  2025cites this paper
• Animal Approaches to Studying Risk Factors for Parkinson’s Disease: A Narrative Review

  2024cites this paper
• Exploring the Central Mechanisms of Botulinum Toxin in Parkinson’s Disease: A Systematic Review from Animal Models to Human Evidence

  2023cites this paper
• Effects of bariatric surgery and dietary interventions for obesity on brain neurotransmitter systems and metabolism: A systematic review of positron emission tomography (PET) and single‐photon emission computed tomography (SPECT) studies

  2023cites this paper
• Preventive Vitamin A Supplementation Improves Striatal Function in 6-Hydroxydopamine Hemiparkinsonian Rats

  2022cites this paper
• Investigation of frequency components embedded in EEG recordings underlying neuronal mechanism of cognitive control and attentional functions

  2022cites this paper
• Olfactory Bulb D2/D3 Receptor Availability after Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson’s Disease

  2022cites this paper
• Botulinum Neurotoxins in Central Nervous System: An Overview from Animal Models to Human Therapy

  2021cites this paper
• Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson’s Disease

  2021influential citation
• Interlinking potential therapy with botulinum neurotoxin-A and Parkinson's disease

  2020cites this paper
• Bilateral Parkinson’s disease model rats exhibit hyperalgesia to subcutaneous formalin administration into the vibrissa pad

  2019cites this paper
• Acetylcholine Neurotransmitter Receptor Densities in the Striatum of Hemiparkinsonian Rats Following Botulinum Neurotoxin-A Injection

  2018cites this paper
• Unilateral Botulinum Neurotoxin-A Injection into the Striatum of C57BL/6 Mice Leads to a Different Motor Behavior Compared with Rats

  2018cites this paper
• Exploiting Botulinum Neurotoxins for the Study of Brain Physiology and Pathology

  2018cites this paper
• [18F]fallypride-PET/CT Analysis of the Dopamine D2/D3 Receptor in the Hemiparkinsonian Rat Brain Following Intrastriatal Botulinum Neurotoxin A Injection

  2018cites this paper
• Experimental Intrastriatal Applications of Botulinum Neurotoxin-A: A Review

  2018cites this paper
• Repeated Intrastriatal Botulinum Neurotoxin-A Injection in Hemiparkinsonian Rats Increased the Beneficial Effect on Rotational Behavior

  2018cites this paper